Table II.

Characteristics of patients in the CCRT-alone and CCRT plus adjuvant chemotherapy groups.

A, Acute systemic toxicity during CCRT.
	Non-extended field n=18 (%)	Extended field n=19 (%)	p-value
≥4 cycles of CDDP	14 (78)	13 (68)	0.713
Number of patients with grade 3–4 acute toxicity
Hematologic toxicity	8 (44)	12 (63)	0.121
Leukopenia	7 (38)	11 (58)
Thrombocytopenia	0 (0)	0 (0)
Anemia	1 (5.3)	3 (16)
Gastrointestinal toxicity	1 (5.3)	4 (22)	0.153

B, Acute systemic toxicity during adjuvant chemotherapy.
	Non-extended field n=4 (%)	Extended field n=13 (%)	p-value
Number of patients with grade 3–4 acute hematologic toxicity	4 (100)	13 (100)	NS
Leukopenia	4 (100)	12 (92)
Thrombocytopenia	0 (0)	3 (23)
Anemia	0 (0)	7 (54)

C, Late treatment-related toxicities.
	CCRT-alone (n=20)		CCRT-CTX (n=17)
	Grade 1–2	Grade 3–5	Grade 1–2	Grade 3–5
Site of effect
Gastrointestinal	3	1	2	1
Genitourinary	0	0	1	0
Insufficiency fractures	1	0	2	0